tailieunhanh - Impact of delays in initiating postoperative chemoradiation while determining the MGMT promoter-methylation statuses of patients with primary glioblastoma

The benefits of new innovations in glioblastoma therapies should not be curtailed as a result of delays in commencement of radiation therapy, caused by clinical circumstances as well as diagnostic procedures. This study evaluates whether delays in chemo-radiotherapy after surgery, while determining O6-methylguanineDNA-methyltransferase (MGMT) promoter status, affect the survival rates of patients with glioblastoma (GBM). |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN